Shares in Ocular Therapeutix (NSDQ:OCUL) rose this morning after the company beat expectations on Wall Street with its fourth quarter earnings, but missed analysts’ sales estimates. The company is facing a slew of class action suits from investors, as well as a probe by the Securities and Exchange Commission regarding its post-surgical pain relief implant, Dextenza. Get […]
Sen. Claire McCaskill (D-Mo.) said that Teva Pharmaceuticals (NYSE:TEVA) is “stonewalling” a Senate probe into the the role that opioid manufacturers have in the nation’s opioid crisis. In the senator’s initial inquiries with the generic drugmaker, McCaskill requested an array of documents detailing arrangements between Teva and its customers, as well as internal reviews of pharmacies and […]
Shares in Sorrento Therapeutics (NSDQ:SRNE) soared today after the company announced that the FDA approved its ZTlido lidocaine pain patch designed to treat patients with post-shingles neuralgia. The company resubmitted its application for ZTlido to the FDA last year after it was rejected by the U.S. regulatory agency in 2016. Get the full story at our sister site, Drug […]
PixarBio (OTC:PXRB) faces its own legal problems: a possible lawsuit by the SEC, legal action by a disgruntled employee who is demanding unpaid wages and former landlords looking for $1.8 million in unpaid rent. But the 7-person biotech is also looking to launch some litigation of its own, according to a recent document it filed with the SEC […]
Shares in Pacira Pharmaceuticals (NSDQ:PCRX) fell nearly -16% today after a panel of experts convened by the FDA voted against an expanded use for Pacira’s injectable pain drug. The pharmaceutical company previously submitted an application seeking to use the local anesthetic as a regional pain-killer. Get the full story at our sister site, Drug Delivery Business News.
Relievant Medsystems today released the results from the Smart trial of its Intracept intraosseous nerve ablation system exploring its usefulness at treating chronic lower back pain, touting significant decreases in pain from baseline at three months. The Intracept system is designed to use radio frequency energy delivered through specially designed instruments during a minimally invasive surgical […]
Nobody likes to be on the receiving end of a shot. Studies have found that needle anxiety keeps people from getting important medications, like the flu vaccine, and can even stop people from taking self-injected drugs to manage chronic illnesses. That’s a problem that Portal Instruments hopes to solve with its needle-free injection system. “By the time […]
Ensysce Biosciences said this week that its extended-release oxycodone prodrug won fast track status from the FDA. The San Diego, Calif.-based company is developing the abuse-deterrent drug as a pain management therapy for people with moderate to severe chronic pain. Get the full story at our sister site, Drug Delivery Business News.
Accuray (NSDQ:ARAY) today released data from a study exploring the use of its CyberKnife system used in stereotactic radiosurgery procedures for patients with trigeminal neuralgia, touting rapid and long-lasting pain relief with minimal side effects. Results from the study were published in the journal Neurosurgery, the Sunnyvale, Calif.-based company said. “This study is important because it reinforces […]
Electrocore said today it won FDA 510(k) clearance for its GammaCore device, expanding indications to include the acute treatment of pain associated with migraines in adult patients. The Basking Ridge, N.J.-based company’s GammaCore device is a non-invasive, hand-held vagus nerve stimulation device designed for the reduction of pain. The system is intended to be applied to […]
Cefaly yesterday released data from a trial of its Cefaly Acute device designed for the acute treatment of migraines, touting that its migraine abortion capabilities outperformed current published data on triptans and other medical drugs under investigation for the acute treatment of migraines. The New York City-based company’s flagship Cefaly Acute device is FDA-approved as […]